<PAGE> 1
OMB APPROVAL
OMB Number: 3235-0145
Expires: December 31, 1997
Estimated average burden
hours per response...14.90
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO.______________)*
NEOPHARM INC.
- -------------------------------------------------------------------------------
(NAME OF ISSUER)
Common Stock
- -------------------------------------------------------------------------------
(Title of Class of Securities)
640919 10 6
--------------------
(CUSIP Number)
Check the following box if a fee is being paid with the statement / /. (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such
class.)(See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") of otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 4 pages
SEC 1745 (2-95)
<PAGE> 2
CUSIP NO. 640919 10 6 13G PAGE 2 OF 4 PAGES
----------- ------ -----
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Aquilur Rahman
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) / /
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
- -------------------------------------------------------------------------------
5 SOLE VOTING POWER
865,540
NUMBER OF ---------------------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY -0-
EACH ---------------------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 865,540
---------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
-0-
- -------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
865,540
- -------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- -------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
10.65%
- -------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILING OUT!
<PAGE> 3
Schedule 13G Cusip No. 640919 10 6
Item 1
(a) Name of Issuer: NeoPharm,Inc.
(b) Address of Issuer's Principal Executive Offices: 225 E. Deerpath
Road, Suite 250, Lake Forest, Illinois 60045
Item 2
(a) Name of person filing: Aquilur Rahman
(b) Address of Principal Business Office: 225 E. Deerpath Road, Suite
250, Lake Forest, Illinois 60045
(c) Citizenship: U.S.A.
(d) Title of Class of Securities: Common Stock
(e) Cusip No.: 640919 10 6
Item 3
If the statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) check
whether the person filing is a:
Not Applicable
Item 4 Ownership
(a) Amount beneficially owned: 865,540 shares
(b) Percent of Class: 10.65%
(c) Numbers of shares as to which this person has:
(i) Sole voting: power: 865,540
(ii) Shared voting power: 0
(iii) Sole dispositive power: 865,540
(iv) Shared dispositive power: 0
Item 5 Ownership of Five Percent or Less of a Class:
Not Applicable
Page 3 of 4 pages
<PAGE> 4
Item 6 Ownership of More than Five Percent on Behalf of Another Person:
Not Applicable
Item 7 Identification and classification of a subsidiary which acquired the
security being reported on by the parent holding company:
Not Applicable
Item 8 Identification and classification of members of the group:
Not Applicable
Item 9 Notice of dissolution of group:
Not Applicable
Item 10 Certification:
Not Applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 11, 1997 /s/ Aquilur Rahman
-----------------------------
Aquilur Rahman, Director
and Chief Scientific Officer
Page 4 of 4 pages
